Skip to main content

Advertisement

SpringerLink
Log in

Why is polymyalgia rheumatica a disease of older adults? Explanations through etiology and pathogenesis: a narrative review

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Polymyalgia rheumatica is one of the most common inflammatory rheumatic conditions in older adults. The disease is characterized by pain and stiffness in the shoulder and pelvic girdle. Polymyalgia rheumatica is almost always observed in adults over the age of 50. The current article aimed to provide explanations for the age preference of polymyalgia rheumatica by reviewing the literature regarding disease etiology and pathogenesis. Potential factors related to the association between polymyalgia rheumatica and aging include immunosenescence/inflammaging, increased risk of infections by aging, endocrinosenescence, and age-related changes in gut microbiota. These factors and their potential contributions to immune-mediated inflammation will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Coskun Benlidayi I, Gokce KY (2021) Antirheumatic drug use in elderly and polypharmacy issues. Z Gerontol Geriatr. https://doi.org/10.1007/s00391-021-01907-6

  2. Matteson EL, Dejaco C (2017) Polymyalgia rheumatica. Ann Intern Med 166(9):ITC65–ITC80. https://doi.org/10.7326/AITC201705020

    Article  PubMed  Google Scholar 

  3. Raleigh MF, Stoddard J, Darrow HJ (2022) Polymyalgia rheumatica and giant cell arteritis: rapid evidence review. Am Fam Physician 106(4):420–426

    PubMed  Google Scholar 

  4. Colombo MG, Wetzel AJ, Haumann H, Dally S, Kirtschig G, Joos S (2022) Polymyalgia rheumatica. Dtsch Arztebl Int 119(24):411–417. https://doi.org/10.3238/arztebl.m2022.0218

    Article  PubMed  Google Scholar 

  5. Lundberg IE, Sharma A, Turesson C, Mohammad AJ (2022) An update on polymyalgia rheumatica. J Intern Med 292(5):717–732. https://doi.org/10.1111/joim.13525

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Camellino D, Giusti A, Girasole G, Bianchi G, Dejaco C (2019) Pathogenesis, diagnosis and management of polymyalgia rheumatica. Drugs Aging 36(11):1015–1026. https://doi.org/10.1007/s40266-019-00705-5

    Article  PubMed  Google Scholar 

  7. Coskun Benlidayi I, Gokce KY (2021) A spiral of cumulative problems: gerontorheumatology. Turk J Geriatrics 24(4):441–450. https://doi.org/10.31086/tjgeri.2021.242

    Article  Google Scholar 

  8. Buttgereit F, Dejaco C, Matteson EL, Dasgupta B (2016) Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA 315(22):2442–2458. https://doi.org/10.1001/jama.2016.5444

    Article  PubMed  CAS  Google Scholar 

  9. Ruta S, Rosa J, Navarta DA, Saucedo C, Catoggio LJ, Monaco RG, Soriano ER (2012) Ultrasound assessment of new onset bilateral painful shoulder in patients with polymyalgia rheumatica and rheumatoid arthritis. Clin Rheumatol 31(9):1383–1387. https://doi.org/10.1007/s10067-012-2016-2

    Article  PubMed  Google Scholar 

  10. Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, Bachta A, Dejaco C, Duftner C, Jensen HS, Duhaut P, Poór G, Kaposi NP, Mandl P, Balint PV, Schmidt Z, Iagnocco A, Nannini C, Cantini F et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71(4):484–492. https://doi.org/10.1136/annrheumdis-2011-200329

    Article  PubMed  Google Scholar 

  11. Pean de Ponfilly-Sotier M, Besson FL, Gomez L, Ottaviani S, Dieudé P, Pavy S, Mariette X, Seror R, Nocturne G (2022) Use of 18F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice. Joint Bone Spine 89(3):105325. https://doi.org/10.1016/j.jbspin.2021.105325

    Article  PubMed  Google Scholar 

  12. Owen CE, Poon AMT, Yang V, McMaster C, Lee ST, Liew DFL, Leung JL, Scott AM, Buchanan RRC (2020) Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity. Eur J Nucl Med Mol Imaging 47(10):2461–2468. https://doi.org/10.1007/s00259-020-04731-z

    Article  PubMed  Google Scholar 

  13. Tanaka Y, Tanaka S, Takahashi T, Kato N (2023) Clinical features of polymyalgia rheumatica patients in Japan: analysis of real-world data from 2015 to 2020. Mod Rheumatol:road026. https://doi.org/10.1093/mr/road026

  14. Kermani TA, Warrington KJ (2013) Polymyalgia rheumatica. Lancet 381(9860):63–72. https://doi.org/10.1016/S0140-6736(12)60680-1 Epub 2012 Oct 8. Erratum in: Lancet. 2013 Jan 5;381(9860):28

    Article  PubMed  Google Scholar 

  15. Patil P, Dasgupta B (2013) Polymyalgia rheumatica in older adults. Aging Health 9(5):483–495. https://doi.org/10.2217/ahe.13.50

    Article  CAS  Google Scholar 

  16. Dejaco C, Duftner C, Al-Massad J, Wagner AD, Park JK, Fessler J, Aigelsreiter A, Hafner F, Vega S, Sterlacci W, Grubeck-Loebenstein B, Tzankov A, Ness T, Boiardi L, Salvarani C, Schirmer M (2013) NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica. Ann Rheum Dis 72(11):1852–1859. https://doi.org/10.1136/annrheumdis-2012-201660

    Article  PubMed  CAS  Google Scholar 

  17. Scrivo R, Gerardi MC, Rutigliano I, Sessa P, Mipatrini D, Stricchiola GMG, Pacella E, Altobelli A, Castellani C, Alessandri C, Ceccarelli F, Di Franco M, Priori R, Riccieri V, Sili Scavalli A, Spinelli FR, La Torre G, Conti F, Valesini G (2018) Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study. Clin Rheumatol 37(9):2573–2577. https://doi.org/10.1007/s10067-018-4137-8

    Article  PubMed  Google Scholar 

  18. Carvajal Alegria G, Boukhlal S, Cornec D, Devauchelle-Pensec V (2020) The pathophysiology of polymyalgia rheumatica, small pieces of a big puzzle. Autoimmun Rev 19(11):102670. https://doi.org/10.1016/j.autrev.2020.102670

    Article  PubMed  CAS  Google Scholar 

  19. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417. https://doi.org/10.1007/s00296-011-1999-3

    Article  PubMed  Google Scholar 

  20. Reviron D, Foutrier C, Guis S, Mercier P, Roudier J (2001) DRB1 alleles in polymyalgia rheumatica and rheumatoid arthritis in southern France. Eur J Immunogenet 28(1):83–87. https://doi.org/10.1046/j.1365-2370.2001.00228.x

    Article  PubMed  CAS  Google Scholar 

  21. Soriano A, Landolfi R, Manna R (2012) Polymyalgia rheumatica in 2011. Best Pract Res Clin Rheumatol 26(1):91–104. https://doi.org/10.1016/j.berh.2012.01.007

    Article  PubMed  Google Scholar 

  22. González-Gay MA, García-Porrúa C, Vázquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE (1999) The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol 26(6):1326–1332

    PubMed  Google Scholar 

  23. Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D, Farnetti E, Brini M, Portioli I (2000) Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. J Rheumatol 27(5):1215–1221

    PubMed  CAS  Google Scholar 

  24. Mattey DL, Hajeer AH, Dababneh A, Thomson W, González-Gay MA, García-Porrúa C, Ollier WE (2000) Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum 43(8):1749–1755. https://doi.org/10.1002/1529-0131(200008)43:8<1749::AID-ANR11>3.0.CO;2-K

    Article  PubMed  CAS  Google Scholar 

  25. Boiardi L, Salvarani C, Timms JM, Silvestri T, Macchioni PL, di Giovine FS (2000) Interleukin-1 cluster and tumor necrosis factor-alpha gene polymorphisms in polymyalgia rheumatica. Clin Exp Rheumatol 18(6):675–681

    PubMed  CAS  Google Scholar 

  26. Alvarez-Rodriguez L, Carrasco-Marin E, Lopez-Hoyos M, Mata C, Fernandez-Prieto L, Ruiz-Soto M, Calvo J, Rodriguez-Valverde V, Ruiz T, Blanco R, Corrales A, Martinez-Taboada VM (2009) Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: association of IL-1RN*2/2 genotype with polymyalgia rheumatica. Hum Immunol 70(1):49–54. https://doi.org/10.1016/j.humimm.2008.10.011

    Article  PubMed  CAS  Google Scholar 

  27. Martinez-Taboada VM, Alvarez L, RuizSoto M, Marin-Vidalled MJ, Lopez-Hoyos M (2008) Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment. Cytokine 44(2):207–220. https://doi.org/10.1016/j.cyto.2008.09.004

    Article  PubMed  CAS  Google Scholar 

  28. Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C (2006) Relationship between interleukin 6 promoter polymorphism at position −174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol 33(4):703–708

    PubMed  CAS  Google Scholar 

  29. Hysa E, Gotelli E, Sammorì S, Cimmino MA, Paolino S, Pizzorni C, Sulli A, Smith V, Cutolo M (2022) Immune system activation in polymyalgia rheumatica: which balance between autoinflammation and autoimmunity? A systematic review. Autoimmun Rev 21(2):102995. https://doi.org/10.1016/j.autrev.2021.102995

    Article  PubMed  CAS  Google Scholar 

  30. Guggino G, Ferrante A, Macaluso F, Triolo G, Ciccia F (2018) Pathogenesis of polymyalgia rheumatica. Reumatismo 70(1):10–17. https://doi.org/10.4081/reumatismo.2018.1048

    Article  PubMed  CAS  Google Scholar 

  31. van Sleen Y, Graver JC, Abdulahad WH, van der Geest KSM, Boots AMH, Sandovici M, Brouwer E (2019) Leukocyte dynamics reveal a persistent myeloid dominance in giant cell arteritis and polymyalgia rheumatica. Front Immunol 10:1981. https://doi.org/10.3389/fimmu.2019.01981

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Reitsema RD, Jiemy WF, Wekema L, Boots AMH, Heeringa P, Huitema MG, Abdulahad WH, van Sleen Y, Sandovici M, Roozendaal C, Diepstra A, Kwee T, Dasgupta B, Brouwer E, van der Geest KSM (2022) Contribution of pathogenic T helper 1 and 17 cells to bursitis and tenosynovitis in polymyalgia rheumatica. Front Immunol 13:943574. https://doi.org/10.3389/fimmu.2022.943574

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Nadkarni S, Lashin H, Hollywood J, Dasgupta B, Mason JC, Perretti M (2019) Identification of an activated neutrophil phenotype in polymyalgia rheumatica during steroid treatment: a potential involvement of immune cell cross-talk. Clin Sci 133(7):839–851. https://doi.org/10.1042/CS20180415

    Article  CAS  Google Scholar 

  34. Santoro L, Birra D, Bosello S, Nesci A, Di Giorgio A, Peluso G, Giupponi B, Zaccone V, Gasbarrini A, Zoli A, Santoliquido A (2020) Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study. Scand J Rheumatol 49(1):68–74. https://doi.org/10.1080/03009742.2019.1628297

    Article  PubMed  CAS  Google Scholar 

  35. Pirro M, Bocci EB, Di Filippo F, Schillaci G, Mannarino MR, Bagaglia F et al (2012) Imbalance between endothelial injury and repair in patients with polymyalgia rheumatica: improvement with corticosteroid treatment. J Intern Med 272:177–184. https://doi.org/10.1111/j.1365-2796.2011.02510.x

    Article  PubMed  CAS  Google Scholar 

  36. Nakajima S, Chiba A, Makiyama A, Hayashi E, Murayama G, Yamaji K et al (2020) Association of mucosal-associated invariant T cells with different disease phases of polymyalgia rheumatica. Rheumatology 59:2939–2946. https://doi.org/10.1093/rheumatology/keaa054

    Article  PubMed  CAS  Google Scholar 

  37. Michailidou D, Johansson L, Kuley R, Wang T, Hermanson P, Rantapää-Dahlqvist S, Lood C (2022) Immune complex-mediated neutrophil activation in patients with polymyalgia rheumatica. Rheumatology:keac722. https://doi.org/10.1093/rheumatology/keac722

  38. Lee GR (2018) The balance of Th17 versus Treg cells in autoimmunity. Int J Mol Sci 19(3):730. https://doi.org/10.3390/ijms19030730

    Article  MathSciNet  PubMed  PubMed Central  CAS  Google Scholar 

  39. Samson M, Audia S, Fraszczak J, Trad M, Ornetti P, Lakomy D, Ciudad M, Leguy V, Berthier S, Vinit J, Manckoundia P, Maillefert JF, Besancenot JF, Aho-Glele S, Olsson NO, Lorcerie B, Guillevin L, Mouthon L, Saas P et al (2012) Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis. Arthritis Rheum 64(11):3788–3798. https://doi.org/10.1002/art.34647

    Article  PubMed  CAS  Google Scholar 

  40. Garrity D, Call ME, Feng J, Wucherpfennig KW (2005) The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. Proc Natl Acad Sci U S A 102(21):7641–7646. https://doi.org/10.1073/pnas.0502439102

    Article  ADS  PubMed  PubMed Central  CAS  Google Scholar 

  41. Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA, Martin J (2006) Giant cell arteritis and polymyalgia rheumatica pathophysiology and management. Drugs Aging 23(8):627–649. https://doi.org/10.2165/00002512-200623080-00002

    Article  PubMed  Google Scholar 

  42. van der Geest KS, Abdulahad WH, Chalan P, Rutgers A, Horst G, Huitema MG, Roffel MP, Roozendaal C, Kluin PM, Bos NA, Boots AM, Brouwer E (2014) Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 66(7):1927–1938. https://doi.org/10.1002/art.38625

    Article  CAS  Google Scholar 

  43. van der Geest KS, Abdulahad WH, Rutgers A, Horst G, Bijzet J, Arends S, Roffel MP, Boots AM, Brouwer E (2015) Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica. Rheumatology 54(8):1397–1402. https://doi.org/10.1093/rheumatology/keu526

    Article  PubMed  CAS  Google Scholar 

  44. Rosato E, Salsano F (2008) Immunity, autoimmunity and autoimmune diseases in older people. J Biol Regul Homeost Agents 22(4):217–224

    PubMed  CAS  Google Scholar 

  45. Li X, Li C, Zhang W, Wang Y, Qian P, Huang H (2023) Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct Target Ther 8(1):239. https://doi.org/10.1038/s41392-023-01502-8

    Article  PubMed  PubMed Central  Google Scholar 

  46. Schmitz CRR, Maurmann RM, Guma FTCR, Bauer ME, Barbé-Tuana FM (2023) cGAS-STING pathway as a potential trigger of immunosenescence and inflammaging. Front Immunol 14:1132653. https://doi.org/10.3389/fimmu.2023.1132653

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  47. Bryl E, Witkowski JM (2009) Autoimmunity and autoimmune diseases in the elderly. In: Fulop T, Franceschi C, Hirokawa K, Pawelec G (eds) Handbook on Immunosenescence. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9063-9_51

    Chapter  Google Scholar 

  48. Lian J, Yue Y, Yu W, Zhang Y (2020) Immunosenescence: a key player in cancer development. J Hematol Oncol 13(1):151. https://doi.org/10.1186/s13045-020-00986-z

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Mohan SV, Liao YJ, Kim JW, Goronzy JJ, Weyand CM (2011) Giant cell arteritis: immune and vascular aging as disease risk factors. Arthritis Res Ther 13(4):231. https://doi.org/10.1186/ar3358

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Dejaco C, Duftner C, Schirmer M (2006) Are regulatory T-cells linked with aging? Exp Gerontol 41(4):339–345. https://doi.org/10.1016/j.exger.2006.01.008

    Article  PubMed  CAS  Google Scholar 

  51. Millerand M, Berenbaum F, Jacques C (2019) Danger signals and inflammaging in osteoarthritis. Clin Exp Rheumatol 37 Suppl 120(5):48–56

    PubMed  Google Scholar 

  52. Loeser RF, Collins JA, Diekman BO (2016) Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol 12(7):412–420. https://doi.org/10.1038/nrrheum.2016.65

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Gazitt T, Zisman D, Gardner G Polymyalgia rheumatica: a common disease in seniors. Curr Rheumatol Rep 22(8):40. https://doi.org/10.1007/s11926-020-00919-2

  54. Poudel P, Yu J (2020) Geriatric rheumatology: the need for a separate subspecialty in the near future. Cureus 12(6):e8474. https://doi.org/10.7759/cureus.8474

    Article  PubMed  PubMed Central  Google Scholar 

  55. Rezuș E, Cardoneanu A, Burlui A, Luca A, Codreanu C, Tamba BI, Stanciu GD, Dima N, Bădescu C, Rezuș C (2019) The link between inflammaging and degenerative joint diseases. Int J Mol Sci 20(3):614. https://doi.org/10.3390/ijms20030614

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Gay S, Wilson AG (2014) The emerging role of epigenetics in rheumatic diseases. Rheumatology 53(3):406–414. https://doi.org/10.1093/rheumatology/ket292

    Article  PubMed  Google Scholar 

  57. Gowers IR, Walters K, Kiss-Toth E, Read RC, Duff GW, Wilson AG (2011) Age-related loss of CpG methylation in the tumour necrosis factor promoter. Cytokine 56(3):792–797. https://doi.org/10.1016/j.cyto.2011.09.009

    Article  PubMed  CAS  Google Scholar 

  58. Duhaut P, Bosshard S, Dumontet C (2000) Giant cell arteritis and polymyalgia rheumatica: role of viral infections. Clin Exp Rheumatol 18(4 Suppl 20):S22–S23

    PubMed  CAS  Google Scholar 

  59. Metyas S, Chen C, Aung T, Ballester A, Cheav S (2022) Rheumatologic manifestations of post SARS-CoV-2 infection: a case series. Curr Rheumatol Rev. https://doi.org/10.2174/1573397118666220211155716

  60. Gerardi MC, Rutigliano IM, Scrivo R, Priori R, Riccieri V, Valesini G (2016) “In sickness and in health”: the peculiar occurrence of polymyalgia rheumatica in married cohabiting couples—a case series and review of the literature. Clin Rheumatol 35(4):1111–1115. https://doi.org/10.1007/s10067-014-2604-4

    Article  PubMed  Google Scholar 

  61. Ursini F, Ruscitti P, Addimanda O, Foti R, Raimondo V, Murdaca G, Caira V, Pigatto E, Cuomo G, Lo Gullo A, Cavazzana I, Campochiaro C, Naclerio C, De Angelis R, Ciaffi J, Mancarella L, Brusi V, Marchetti E, Motta F et al (2023) Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group. RMD Open 9(2):e003022. https://doi.org/10.1136/rmdopen-2023-003022

    Article  PubMed  Google Scholar 

  62. Gavazzi G, Krause KH (2002) Ageing and infection. Lancet Infect Dis 2(11):659–666. https://doi.org/10.1016/s1473-3099(02)00437-1

    Article  PubMed  Google Scholar 

  63. Singh JA, Cleveland JD (2020) Serious infections in people with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA): a time-trend national US study. Clin Rheumatol 39(11):3427–3438. https://doi.org/10.1007/s10067-020-05129-w

    Article  PubMed  Google Scholar 

  64. Spies CM, Straub RH, Cutolo M, Buttgereit F (2014) Circadian rhythms in rheumatology—a glucocorticoid perspective. Arthritis Res Ther 16 Suppl 2(Suppl 2):S3. https://doi.org/10.1186/ar4687

    Article  PubMed  Google Scholar 

  65. Gupta D, Morley JE (2014) Hypothalamic-pituitary-adrenal (HPA) axis and aging. Compr Physiol 4(4):1495–1510. https://doi.org/10.1002/cphy.c130049

    Article  PubMed  Google Scholar 

  66. Gaffey AE, Bergeman CS, Clark LA, Wirth MM (2016) Aging and the HPA axis: stress and resilience in older adults. Neurosci Biobehav Rev 68:928–945. https://doi.org/10.1016/j.neubiorev.2016.05.036

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Cutolo M, Foppiani L, Minuto F (2002) Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Investig 25(10 Suppl):19–23

    CAS  Google Scholar 

  68. Cutolo M, Straub RH, Foppiani L, Prete C, Pulsatelli L, Sulli A, Boiardi L, Macchioni P, Giusti M, Pizzorni C, Seriolo B, Salvarani C (2002) Adrenal gland hypofunction in active polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol 29(4):748–756

    PubMed  CAS  Google Scholar 

  69. Narváez J, Bernad B, Díaz Torné C, Momplet JV, Montpel JZ, Nolla JM, Valverde-García J (2006) Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis. J Rheumatol 33(7):1293–1298

    PubMed  Google Scholar 

  70. Kreiner FF, Galbo H (2012) Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment. Arthritis Res Ther 14(4):R186. https://doi.org/10.1186/ar4017

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  71. Sulli A, Montecucco CM, Caporali R, Cavagna L, Montagna P, Capellino S, Fazzuoli L, Seriolo B, Alessandro C, Secchi ME, Cutolo M (2006) Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis. Ann N Y Acad Sci 1069:307–314. https://doi.org/10.1196/annals.1351.029

    Article  ADS  PubMed  CAS  Google Scholar 

  72. Pacheco MJ, Amado JA, Lopez-Hoyos M, Blanco R, Garcia-Unzueta MT, Rodriguez-Valverde V, Martinez-Taboada VM (2003) Hypothalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis. Semin Arthritis Rheum 32(4):266–272. https://doi.org/10.1053/sarh.2003.49993

    Article  PubMed  CAS  Google Scholar 

  73. Kreiner F, Galbo H (2010) Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica. Scand J Rheumatol 39(5):402–408. https://doi.org/10.3109/03009741003631479

    Article  PubMed  CAS  Google Scholar 

  74. Akintola AA, van Heemst D (2015) Insulin, aging, and the brain: mechanisms and implications. Front Endocrinol 6:13. https://doi.org/10.3389/fendo.2015.00013

    Article  Google Scholar 

  75. La Barbera L, Macaluso F, Fasano S, Grasso G, Ciccia F, Guggino G (2022) Microbiome changes in connective tissue diseases and vasculitis: focus on metabolism and inflammation. Int J Mol Sci 23(12):6532. https://doi.org/10.3390/ijms23126532

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  76. Wang Y, Wei J, Zhang W, Doherty M, Zhang Y, Xie H, Li W, Wang N, Lei G, Zeng C (2022) Gut dysbiosis in rheumatic diseases: a systematic review and meta-analysis of 92 observational studies. EBioMedicine 80:104055. https://doi.org/10.1016/j.ebiom.2022.104055

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Han H, Li Y, Fang J, Liu G, Yin J, Li T, Yin Y (2018) Gut microbiota and type 1 diabetes. Int J Mol Sci 19(4):995. https://doi.org/10.3390/ijms19040995

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Lupu VV, Trandafir LM, Raileanu AA, Mihai CM, Morariu ID, Starcea IM, Mocanu A, Butnariu LI, Stoleriu G, Salaru DL, Chisnoiu T, Munteanu D, Mitrofan C, Lupu A (2023) Advances in understanding the human gut microbiota and its implication in pediatric celiac disease—a narrative review. Nutrients 15(11):2499. https://doi.org/10.3390/nu15112499

    Article  PubMed  PubMed Central  Google Scholar 

  79. Zhou C, Zhao H, Xiao XY, Chen BD, Guo RJ, Wang Q, Chen H, Zhao LD, Zhang CC, Jiao YH, Ju YM, Yang HX, Fei YY, Wang L, Shen M, Li H, Wang XH, Lu X, Yang B et al (2020) Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis. J Autoimmun 107:102360. https://doi.org/10.1016/j.jaut.2019.102360

    Article  PubMed  CAS  Google Scholar 

  80. Harkins P, Burke E, Swales C, Silman A (2021) ‘All disease begins in the gut’—the role of the intestinal microbiome in ankylosing spondylitis. Rheumatol Adv Pract 5(3):rkab063. https://doi.org/10.1093/rap/rkab063

    Article  PubMed  PubMed Central  Google Scholar 

  81. Attur M, Scher JU, Abramson SB, Attur M (2022) Role of intestinal dysbiosis and nutrition in rheumatoid arthritis. Cells 11(15):2436. https://doi.org/10.3390/cells11152436

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  82. Brandl C, Bucci L, Schett G, Zaiss MM (2021) Crossing the barriers: revisiting the gut feeling in rheumatoid arthritis. Eur J Immunol 51(4):798–810. https://doi.org/10.1002/eji.202048876

    Article  PubMed  CAS  Google Scholar 

  83. Xu H, Zhao H, Fan D, Liu M, Cao J, Xia Y, Ju D, Xiao C, Guan Q (2020) Interactions between gut microbiota and immunomodulatory cells in rheumatoid arthritis. Mediat Inflamm 2020:1430605. https://doi.org/10.1155/2020/1430605

    Article  CAS  Google Scholar 

  84. Zaiss MM, Joyce Wu HJ, Mauro D, Schett G, Ciccia F (2021) The gut-joint axis in rheumatoid arthritis. Nat Rev Rheumatol 17(4):224–237. https://doi.org/10.1038/s41584-021-00585-3

    Article  PubMed  Google Scholar 

  85. Katz-Agranov N, Zandman-Goddard G (2017) The microbiome and systemic lupus erythematosus. Immunol Res 65(2):432–437. https://doi.org/10.1007/s12026-017-8906-2

    Article  PubMed  CAS  Google Scholar 

  86. Breban M, Tap J, Leboime A, Said-Nahal R, Langella P, Chiocchia G, Furet JP, Sokol H (2017) Faecal microbiota study reveals specific dysbiosis in spondyloarthritis. Ann Rheum Dis 76(9):1614–1622. https://doi.org/10.1136/annrheumdis-2016-211064

    Article  PubMed  CAS  Google Scholar 

  87. Mauro D, Ciccia F (2019) Gut dysbiosis in spondyloarthritis: cause or effect? Best Pract Res Clin Rheumatol 33(6):101493. https://doi.org/10.1016/j.berh.2020.101493

    Article  PubMed  Google Scholar 

  88. Matei DE, Menon M, Alber DG, Smith AM, Nedjat-Shokouhi B, Fasano A, Magill L, Duhlin A, Bitoun S, Gleizes A, Hacein-Bey-Abina S, Manson JJ, Rosser EC, ABIRISK Consortium, Klein N, Blair PA, Mauri C (2021) Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease. Med 2(7):864–883.e9. https://doi.org/10.1016/j.medj.2021.04.013

    Article  PubMed  CAS  Google Scholar 

  89. Rahman Z, Dandekar MP (2022) Implication of paraprobiotics in age-associated gut dysbiosis and neurodegenerative diseases. NeuroMolecular Med. https://doi.org/10.1007/s12017-022-08722-1

  90. Vemuri RC, Gundamaraju R, Shinde T, Eri R (2017) Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation? Benefic Microbes 8(2):179–192. https://doi.org/10.3920/BM2016.0115

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Cukurova University, Adana, Turkey

    Ilke Coskun Benlidayi

Authors
  1. Ilke Coskun Benlidayi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ilke Coskun Benlidayi.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals performed by the author.

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coskun Benlidayi, I. Why is polymyalgia rheumatica a disease of older adults? Explanations through etiology and pathogenesis: a narrative review. Clin Rheumatol 43, 851–861 (2024). https://doi.org/10.1007/s10067-023-06708-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-023-06708-3

Keywords

Search

Navigation